MD Anderson Cancer Center at Cooper — Camden, New Jersey

MD Anderson Cancer Center at Cooper is a clinical research site located in Camden, New Jersey, United States 08103.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center at Cooper has participated in 25 clinical trials with 11 currently active.

Therapeutic areas: Insomnia, Pancreas Cancer, Pancreatic Cancer.

Sponsors: The Cooper Health System, NovoCure GmbH, Pfizer.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center at Cooper?

MD Anderson Cancer Center at Cooper has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center at Cooper conducted?

MD Anderson Cancer Center at Cooper has 25 clinical trials on record, with 11 currently active. Their work covers Insomnia, Pancreas Cancer, Pancreatic Cancer.

Is MD Anderson Cancer Center at Cooper accredited by Crixeo Health?

MD Anderson Cancer Center at Cooper has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center at Cooper?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.